Floatz logo

HYDROMORPHONE HYDROCHLORIDE CII

Multimodal Analgesia

First Affiliated Hospital, Sun Yat-Sen UniversitySmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Multimodal Analgesia cohort.

Asset / SponsorPhaseRating
HYDROMORPHON
First Affiliated Hospital, Sun Yat-Sen University
Phase 4BB
Flurbiprofen Axetil
First Affiliated Hospital, Sun Yat-Sen University
Phase 4B

Same molecule, other indications

HYDROMORPHONE HYDROCHLORIDE CII is also rated in:

Real-world StudyDormant
BB
Indicative ·
69 / 100
View asset →
Transarterial ChemoembolizationDormant
BB
Indicative ·
68 / 100
View asset →
Enhanced Recovery After SurgeryDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →